These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2898643)

  • 1. Coagulation factor VIII concentrates and the marketplace.
    Lancet; 1988 Jul; 2(8601):42-3. PubMed ID: 2898643
    [No Abstract]   [Full Text] [Related]  

  • 2. Coagulation factor VIII concentrates and the marketplace.
    Cash JD
    Lancet; 1988 Jun; 1(8597):1270. PubMed ID: 2897528
    [No Abstract]   [Full Text] [Related]  

  • 3. High potency factor VIII concentrates.
    BMJ; 1991 Oct; 303(6809):1061-2. PubMed ID: 1954471
    [No Abstract]   [Full Text] [Related]  

  • 4. Factor VIII solutions in pre-filled syringes.
    Peerlinck K; Arnout J; Vermylen J
    Lancet; 1992 Feb; 339(8788):303-4. PubMed ID: 1346301
    [No Abstract]   [Full Text] [Related]  

  • 5. [Improvement in anti-hemophilic preparations and arts problems. 1. Heat-treated concentrates].
    Ikematsu S; Yorifuji H; Arai M; Fukutake K
    Rinsho Ketsueki; 1988 May; 29(5):628-34. PubMed ID: 3145993
    [No Abstract]   [Full Text] [Related]  

  • 6. Viral safety and inhibitor development associated with monoclonal antibody-purified F VIII C.
    Lusher JM
    Ann Hematol; 1991 Sep; 63(3):138-41. PubMed ID: 1932288
    [No Abstract]   [Full Text] [Related]  

  • 7. Antihemophilic factor isolated with monoclonal antibodies.
    Gomperts ED
    Ann Hematol; 1991 Sep; 63(3):142-4. PubMed ID: 1932289
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro characteristics of highly purified factor VIII concentrates.
    Morfini M
    Ann Hematol; 1991 Sep; 63(3):123-5. PubMed ID: 1932286
    [No Abstract]   [Full Text] [Related]  

  • 9. Characterization of highly purified factor VIII products.
    Beeser H
    Ann Hematol; 1991 Sep; 63(3):126-30. PubMed ID: 1657208
    [No Abstract]   [Full Text] [Related]  

  • 10. B19 parvovirus withstands "super heating" in antihemophilic concentrates.
    Morfini M; Azzi A; Mannucci PM
    Thromb Haemost; 1996 Nov; 76(5):821. PubMed ID: 8950802
    [No Abstract]   [Full Text] [Related]  

  • 11. [Improvement in anti-hemophilic preparations and its problems. 4. Factor VIII preparation (RCG-5) with intermediate purity and potency].
    Yoshioka A
    Rinsho Ketsueki; 1988 May; 29(5):649-54. PubMed ID: 3145996
    [No Abstract]   [Full Text] [Related]  

  • 12. Recombinant factor VIII in hemophilia A: the Canadian experience.
    Blanchette VS
    Blood Coagul Fibrinolysis; 1997 Aug; 8 Suppl 1():S33-9. PubMed ID: 9351535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrapure plasma factor VIII produced by anti-F VIII c immunoaffinity chromatography and solvent/detergent viral inactivation. Characterization of the Method M process and Hemofil M antihemophilic factor (human).
    Griffith M
    Ann Hematol; 1991 Sep; 63(3):131-7. PubMed ID: 1932287
    [No Abstract]   [Full Text] [Related]  

  • 14. [Plasma concentrates of factor VIII. Where are we?].
    Vicente V
    Sangre (Barc); 1989 Feb; 34(1):1-3. PubMed ID: 2496481
    [No Abstract]   [Full Text] [Related]  

  • 15. Purity of concentrates for substitution therapy: acceptable and undesirable contaminants--Madrid 1978.
    Scand J Haematol Suppl; 1980; 35():65-89. PubMed ID: 6770460
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of factor VIII concentrates on the immune system in hemophilic patients.
    Schulman S
    Ann Hematol; 1991 Sep; 63(3):145-51. PubMed ID: 1932290
    [No Abstract]   [Full Text] [Related]  

  • 17. [Preparation and use of factor VIII concentrates in hemophilia].
    Vilar JM; Ortega F; Martin-Arias DM; Vazquez J; Navarro JL
    Sangre (Barc); 1969; 14(1):57-64. PubMed ID: 5792112
    [No Abstract]   [Full Text] [Related]  

  • 18. The treatment of classical hemophilia with factor 8 concentrates.
    Waterbury L; Frenkel EP
    Clin Anesth; 1968; 3():288-97. PubMed ID: 4902367
    [No Abstract]   [Full Text] [Related]  

  • 19. Recombinant antihemophilic factor.
    Med Lett Drugs Ther; 1993 Jun; 35(898):51-2. PubMed ID: 8497206
    [No Abstract]   [Full Text] [Related]  

  • 20. [Anti-hemophilia drugs: from cryoprecipitate to factor VIII concentrates of high purity].
    Gutsalo AE; Varetskaia TV; Kozulina EP; Papaian LP
    Ukr Biokhim Zh (1978); 1995; 67(1):3-13. PubMed ID: 8588250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.